News & Perspective

Dec 12, 2008

Dec 12, 2008

CDC sees early-season signs of Tamiflu resistance

(CIDRAP News) – With this year's US influenza epidemic barely getting started, there are already signs of increased viral resistance to oseltamivir (Tamiflu), the most widely used antiviral drug, the Centers for Disease Control and Prevention (CDC) said today.

In its flu surveillance report for Nov 30 to Dec 6, released today, the CDC said 45 of 46 influenza A/H1N1 viruses tested so far have shown resistance to oseltamivir.

Oct 27, 2008

Oct 27, 2008

Drug-resistant flu viruses cause growing concern

– WASHINGTON, DC (CIDRAP News) – Health officials worldwide are becoming increasingly concerned about influenza viruses' resistance to antiviral drugs, which can shut down a flu infection or mitigate symptoms. Flu antivirals are vital for reducing severe illness and death in average flu seasons and could be essential bulwarks against an influenza pandemic if one began.

Sep 05, 2008

Sep 05, 2008

Dutch patient dies from Tamiflu-resistant H1N1 virus

(CIDRAP News) – Amid concern about rising resistance to oseltamivir (Tamiflu) in influenza A/H1N1 viruses, a Dutch team this week reported the death of a leukemia patient who was infected with an H1N1 virus that was resistant to the antiviral drug.

Aug 25, 2008

Aug 25, 2008

H1N1 flu viruses growing more resistant to Tamiflu

(CIDRAP News) – With influenza season well under way in the southern hemisphere, one of the three kinds of seasonal influenza virus is becoming increasingly resistant to the antiviral drug oseltamivir (Tamiflu), the World Health Organization (WHO) reported last week.

May 06, 2008

May 06, 2008

Pew report urges limiting antimicrobial use in animals

(CIDRAP News) – After a 2-year study of the effects of large-scale farm animal production, a panel of experts has called for phasing out the nontherapeutic use of antimicrobials in farm animals in order to maintain the effectiveness of antibiotics in humans.

Mar 19, 2008

Mar 19, 2008

Researchers warn of resistant flu, foodborne microbes

– ATLANTA (CIDRAP News) – Serious microbial threats, including drug-resistant influenza and foodborne pathogens, remain stubbornly persistent even as unpredictable new threats are emerging, researchers said this week at the leading international conference on new and resurgent infectious diseases.

Feb 07, 2008

Feb 07, 2008

Europe reports further increase in Tamiflu resistance

(CIDRAP News) – European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.

Feb 01, 2008

Feb 01, 2008

Europe says Tamiflu-resistant virus seen in 9 countries

(CIDRAP News) – European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.

Jan 29, 2008

Jan 29, 2008

Europeans find Tamiflu resistance in seasonal flu virus

(CIDRAP News) – An early report on the seasonal influenza strains circulating in Europe reveals that some H1N1 viruses show signs of resistance to the antiviral drug oseltamivir, the European Centre for Disease Prevention and Control (ECDC) reported this week.

Jan 02, 2008

Jan 02, 2008

Air trip by drug-resistant TB patient prompts passenger testing

(CIDRAP News) – Federal health officials recently issued an alert about a woman with multidrug-resistant tuberculosis (MDR TB) who flew from India to the United States in mid December, and efforts are under way to locate and test several of her fellow passengers for the disease.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»